The transaction includes $70m in cash and a $20m retained equity position for Nektar in a new Ampersand portfolio company.

On Monday, Nektar Therapeutics (NKTR) stock saw a modest uptick, ending the day at $1.33 which represents a slight increase of $0.10 or 8.13% from the prior close of $1.23. The stock opened at $1.37 ...

Fintel reports that on November 4, 2024, Piper Sandler initiated coverage of Nektar Therapeutics (NasdaqCM:NKTR) with a ...

California, USA-based biotech Nektar Therapeutics’ (Nasdaq: NKTR) shares closed up more than 8% at $1.33 yesterday after it ...

The latest update is out from Nektar Therapeutics ( (NKTR) ).

Piper Sandler has initiated coverage on Nektar Therapeutics Inc (NASDAQ:NKTR), citing the company’s lead asset ...

After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...

(RTTNews) - Nektar Therapeutics (NKTR), Monday announced a decision to sell its Alabama-based commercial-scale manufacturing facility and PEGylation reagent supply business to Ampersand Capital ...

Nektar Therapeutics (Nasdaq: NKTR), a global biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, today announced that it has entered into a ...

The Alabama Crimson Tide are ranked No. 15 in the nation headed into Week 9 after reaching the top of the AP Poll in Week 5. The massive home win over Georgia now seems buried in the past given ...

KNOXVILLE, Tenn. -- Malachi Moore, the emotional leader of the Alabama football team, started aggressively head-butting his helmet after Jalen Milroe's second interception assured the No. 7 ...

The Southeastern Conference showdown between seventh-ranked Alabama and No. 11 Tennessee was one of the most anticipated games on the Week 8 college football slate. The matchup lived up to the ...